Not logged in Pathologic complete response (pCR) of neoadjuvant therapy with or without atezolizumab in HER2-positive, early high-risk and locally advanced breast cancer: APTneo Michelangelo randomized trial Gianni, Luca; Munzone, Elisabetta; Mansutti, Mauro; Bianchini, Giampaolo; Izarzuzaga, Yann; Caremoli, Elena Rota; Dirix, Luc; Del Mastro, Lucia; Gonzalez-Santiago, Santiago; Schneeweiss, Andreas; Ponce, Jose; Huang, Chiun-Shen; Wimberger, Pauline; Altintas, Sevilay; Martin, Miguel; Antone, Nicoleta; Singer, Christian F.; De Giorgi, Ugo; Ortiz, Ana Godoy; Lueck, Hans-Joachim; Spezia, Riccardo; Fasolo, Angelica; Viale, Giuseppe; Valagussa, Pinuccia Share Save
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple-negative, early high-risk and locally advanced breast cancer: NeoTRIP Michelangelo randomized study* Gianni, L.; Huang, C. S.; Egle, D.; Bermejo, B.; Zamagni, C.; Thill, M.; Anton, A.; Zambelli, S.; Bianchini, G.; Russo, S.; Ciruelos, E. M.; Greil, R.; Semiglazov, V; Colleoni, M.; Kelly, C.; Mariani, G.; Del Mastro, L.; Maffeis, I; Valagussa, P.; Viale, G. Share Save
Triple negative breast cancer subtypes and early dynamics of the 27-gene IO score predict pCR in the NeoTRIPaPDL1 trial Dugo, Matteo; Huang, Chiun-Sheng; Egle, Daniel; Bermejo, Begona; Zamagni, Claudio; Seitz, Robert S.; Nielsen, Tyler J.; Thill, Marc; Anton, Antonio; Russo, Stefania; Ciruelos, Eva Maria; Schweitzer, Brock L.; Ross, Douglas T.; Galbardi, Barbara; Greil, Richard; Semiglazov, Vladimir; Gyorffy, Balazs; Colleoni, Marco; Kelly, Catherine; Mariani, Gabriella; Del Mastro, Lucia; Valagussa, Pinuccia; Viale, Giuseppe; Callari, Maurizio; Gianni, Luca; Bianchini, Giampaolo Share Save
Comparison of early modulation of biological pathways and immune microenvironment by anthracyclines- or taxane-based treatment Callari, Maurizio; Barreca, Marco; Dugo, Matteo; Galbardi, Barbara; Vigano, Lucia; Locatelli, Alberta; Licata, Luca; Viale, Giulia; Valagussa, Pinuccia; Viale, Giuseppe; Gianni, Luca; Bianchini, Giampaolo Share Save
Predictive value of RT-qPCR 27-gene IO score and comparison with RNA-Seq IO score in the NeoTRIPaPDL1 trial Dugo, Matteo; Huang, Chiun-Sheng; Egle, Daniel; Bermejo, Begona; Zamagni, Claudio; Seitz, Robert S.; Nielsen, Tyler J.; Thill, Marc; Anton, Antonio; Russo, Stefania; Ciruelos, Eva Maria; Schweitzer, Brock L.; Ross, Douglas T.; Galbardi, Barbara; Greil, Richard; Semiglazov, Vladimir; Gyorffy, Balazs; Colleoni, Marco; Kelly, Catherine; Mariani, Gabriella; Del Mastro, Lucia; Valagussa, Pinuccia; Viale, Giuseppe; Callari, Maurizio; Gianni, Luca; Bianchini, Giampaolo Share Save
Single-cell spatial analysis by imaging mass cytometry and immunotherapy response in triple-negative breast cancer (TNBC) in the NeoTRIPaPDL1 trial Bianchini, Giampaolo; Wang, Xiao Qian; Danenberg, Esther; Huang, Chiun-Sheng; Egle, Daniel; Callari, Maurizio; Bermejo, Begona; Zamagni, Claudio; Thill, Marc; Anton, Anton; Dugo, Matteo; Zambelli, Stefania; Russo, Stefania; Ciruelos, Eva Maria; Greil, Richard; Semiglazov, Vladimir; Colleoni, Marco; Kelly, Catherine; Mariani, Gabriella; Del Mastro, Lucia; Gyorffy, Balazs; Biasi, Olivia; Valagussa, Pinuccia; Viale, Giuseppe; Gianni, Luca; Ali, H. Raza Share Save
Immune milieu associated with PD-L1 status in TNBC is dependent on time of biomarker assessment and treatment received: A secondary analysis of the NeoTRIPaPDL1 trial Callari, Maurizio; Huang, Chiun-Sheng; Egle, Daniel; Bermejo, Begona; Zamagni, Claudio; Dugo, Matteo; Thill, Marc; Anton, Antonio; Barreca, Marco; Russo, Stefania; Ciruelos, Eva Maria; Greil, Richard; Zambelli, Stefania; Gyorffy, Balazs; Smart, Chanel; Biasi, Olivia; Valagussa, Pinuccia; Viale, Giuseppe; Gianni, Luca; Bianchini, Giampaolo Share Save
Derived Neutrophil-to-Lymphocyte Ratio Predicts Pathological Complete Response to Neoadjuvant Chemotherapy in Breast Cancer Ocana, Alberto; Chacon, Jose Ignacio; Calvo, Lourdes; Anton, Antonio; Mansutti, Mauro; Albanell, Joan; Martinez, Maria Teresa; Lahuerta, Ainhara; Bisagni, Giancarlo; Bermejo, Begona; Semiglazov, Vladimir; Thill, Marc; Chan, Arlene; Morales, Serafin; Herranz, Jesus; Tusquets, Ignacio; Chiesa, Massimo; Caballero, Rosalia; Valagussa, Pinuccia; Bianchini, Giampaolo; Alba, Emilio; Gianni, Luca Share Save
Effects of neoadjuvant trastuzumab, pertuzumab and palbociclib on Ki67 in HER2 and ER-positive breast cancer Gianni, Luca; Colleoni, Marco; Bisagni, Giancarlo; Mansutti, Mauro; Zamagni, Claudio; Del Mastro, Lucia; Zambelli, Stefania; Bianchini, Giampaolo; Frassoldati, Antonio; Maffeis, Ilaria; Valagussa, Pinuccia; Viale, Giuseppe Share Save
The TRAR gene classifier to predict response to neoadjuvant therapy in HER2-positive and ER-positive breast cancer patients: an explorative analysis from the NeoSphere trial Triulzi, Tiziana; Bianchini, Giampaolo; Di Cosimo, Serena; Pienkowski, Tadeusz; Im, Young-Hyuck; Bianchi, Giulia Valeria; Galbardi, Barbara; Dugo, Matteo; De Cecco, Loris; Tseng, Ling-Ming; Liu, Mei-Ching; Bermejo, Begona; Semiglazov, Vladimir; Viale, Giulia; de la Haba-Rodriguez, Juan; Oh, Do-Youn; Poirier, Brigitte; Valagussa, Pinuccia; Gianni, Luca; Tagliabue, Elda Share Save
Gene-expression pathways and dynamics during neoadjuvant chemo-free therapy predict pathologic complete response in ER+/HER2+breast cancer (BC) Dugo, M.; Gyorffy, B.; Bisagni, G.; Colleoni, M. A.; Mansutti, M.; Zamagni, C.; Del Mastro, L.; Zambelli, S.; Frassoldati, A.; Licata, L.; Galbardi, B.; Biasi, O. M.; Vigano, L.; Locatelli, A.; Viale, G.; Valagussa, P.; Viale, G.; Callari, M.; Gianni, L.; Bianchini, G. Share Save
Predictive value of gene-expression profiles (GEPs) and their dynamics during therapy in the NeoTRIPaPDL1 trial Bianchini, G.; Dugo, M.; Huang, C-S.; Egle, D.; Bermejo, B.; Seitz, R. S.; Nielsen, T. J. J.; Zamagni, C.; Thill, M.; Anton, A.; Russo, S.; Ciruelos, E. M.; Schweitzer, B. L.; Greil, R.; Semiglazov, V.; Gyorffy, B.; Valagussa, P.; Viale, G.; Callari, M.; Gianni, L. Share Save
Tumour infiltrating lymphocytes (TILs), PD-L1 expression and their dynamics in the NeoTRIPaPDL1 trial Bianchini, G.; Huang, C-S.; Egle, D.; Bermejo, B.; Zamagni, C.; Thill, M.; Anton, A.; Zambelli, S.; Russo, S.; Ciruelos, E. M.; Greil, R.; Semiglazov, V.; Colleoni, M. A.; Kelly, C. M.; Mariani, G.; Del Mastro, L.; Smart, C.; Valagussa, P.; Viale, G.; Gianni, L. Share Save
Prognostic and predictive value of PML in the ETNA study and the TCGA Zambelli, Stefania; Smart, Chanel; Bianchini, Giampaolo; Sassi, Isabella; Mansutti, Mauro; Anton, Antonio; Calvo, Lourdes; Bisagni, Giancarlo; Bermejo, Begona; Ugge, Martina; Galbardi, Barbara; Semiglazov, Vladimir; Thill, Marc; Chacon, Jose Ignacio; Chan, Arlene; Murillo, Serafin Morales; Alvarez, Isabel; Lahuerta, Ainhara; Zucchinelli, Patrizia; Doglioni, Claudio; Valagussa, Pinuccia; Tusquets, Ignasi; Gianni, Luca; Bernardi, Rosa Share Save
Pathologic complete response (pCR) and prognosis following neoadjuvant chemotherapy plus anti-HER2 therapy of HER2-positive early breast cancer (EBC) Loibl, Sibylle; Untch, Michael; Buyse, Marc; Robidoux, Andre; Gianni, Luca; Schneeweiss, Andreas; Conte, Pierfranco; Piccart, Martine; Bonnefoi, Herve; Jackisch, Christian; Nekljudova, Valentina; Costantino, Joseph; Valagussa, Pinuccia; Neate, Colin; Gelber, Richard; Poncet, Coralie; Squifflet, Pierre; Saad, Everardo; Heinzmann, Dominik; Denkert, Carsten; Geyer, Charles E., Jr.; Cortes, Javier; Guarneri, Valentina; de Azambuja, Evandro; Cameron, David; Ismael, Gustavo; von Minckwitz, Gunter; Wolmark, Norman; Cortazar, Patricia Share Save
Risk of recurrence and death in patients with early HER2-positive breast cancer who achieve a pathological complete response (pCR) after different types of HER2-targeted therapy: A retrospective exploratory analysis Swain, Sandra M.; Macharia, Harrison; Cortes, Javier; Dang, Chau; Gianni, Luca; Hurvitz, Sara; Jackisch, Christian; Schneeweiss, Andreas; Slamon, Dennis; Valagussa, Pinuccia; du Toit, Yolande; Heinzmann, Dominik; Knott, Adam; Song, Chunyan; Cortazar, Patricia Share Save
Modulation of tumor infiltrating lymphocytes (TILs) by palbociclib, trastuzumab, pertuzumab plus /- fulvestrant in ER+/HER2+patients (pts) enrolled in the Michelangelo NA-PHER2 trial Bianchini, Giampaolo; Smart, Chanel; Bisagni, Giancarlo; Colleoni, Marco; Mansutti, Mauro; Zamagni, Claudio; Del Mastro, Lucia; Zambelli, Stefania; Licata, Luca; Frassoldati, Antonio; Viale, Giuseppe; Valagussa, Pinuccia; Gianni, Luca Share Save
Pathologic complete response (pCR) to neoadjuvant treatment with or without atezolizumab in triple negative, early high-risk and locally advanced breast cancer. NeoTRIPaPDL1 Michelangelo randomized study Gianni, Luca; Huang, Chiun-Sheng; Egle, Daniel; Bermejo, Begona; Zamagni, Claudio; Thill, Marc; Anton, Antonio; Zambelli, Stefania; Bianchini, Giampaolo; Russo, Stefania; Ciruelos, Eva; Greil, Richrad; Semiglazov, Vladimir; Colleoni, Marco; Kelly, Catherine; Mariani, Gabriella; Del Mastro, Lucia; Maffeis, Ilaria; Valagussa, Pinuccia; Viale, Giuseppe Share Save
Clinical implication of tumor infiltrating lymphocytes (TILs) in the ETNA study Bianchini, Giampaolo; Smart, Chanel; Mansutti, Mauro; Anton, Antonio; Licata, Luca; Sassi, Isabella; Calvo, Lourdes; Bisagni, Giancarlo; Bermejo, Begona; Semiglazov, Vladimir; Thill, Marc; Chacon, Jose Ignacio; Chan, Arlene; Murillo, Serafin Morales; Alvarez, Isabel; Lahuerta, Ainhara; Zucchinelli, Patrizia; Doglioni, Claudio; Viale, Giuseppe; Valagussa, Pinuccia; Tusquet, Ignasi; Gianni, Luca Share Save
PATINA: A randomized, open label, phase III trial to evaluate the efficacy and safety of palbociclib+antiHER2 therapy + endocrine therapy (ET) vs. anti-HER2 therapy + ET after induction treatment for hormone receptor positive (HR+)/HER2-positive metastatic breast cancer (MBC) Metzger, O.; Mandrekar, S.; Loibl, S.; Mundhenke, C.; Seiler, S.; Valagussa, P.; Lim, E.; Tripathy, D.; Winer, E. P.; Huang, C.; Carey, L.; Francis, P.; Miller, K.; Goetz, M. P.; Prat, A.; Loi, S.; Krop, I.; Gianni, L.; Delalogue, S.; Vaz-Luis, I.; Dockter, T.; Lanzillotti, J.; Ciruelos, E.; DeMichele, A. M. Share Save
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png)
CANCER RESEARCH.png)
.png){kind=icon}
Share.png){kind=icon}
Save